maddyslensecraft - Tumblr blog

[maddyslensecraft]

The global high potency APIs market in terms of revenue was estimated to be worth $24.5 billion in 2022 and is poised to grow at a CAGR of 10.1% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The growth in this market is driven by factors such as increasing demand for oncology drugs, growing demand for antibody-drug conjugates, increasing focus of leading pharmaceutical companies on HPAPIs, advancements in HPAPI manufacturing technologies, and growing focus on precision medicine.

[maddyslensecraft]

High Potency APIs Market / HPAPI Market worth $39.6 billion by 2027

Market Size Estimation:

The research methodology used to estimate the market size includes the following details:

# The key players in the market were identified through secondary research, and their market contributions were determined through primary and secondary research. # This entire procedure included the study of the annual and financial reports of the top market players and extensive interviews for the key insights from industry leaders. # All percentage shares, splits, and breakdowns were determined by secondary sources and verified through primary sources. # All possible parameters affecting the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to reach the final quantitative and qualitative data. # The data mentioned above is consolidated and added with detailed inputs and analyses from MarketsandMarkets and presented in this report.

Projected Surge in Revenue Generation:

The global HPAPI market is projected to reach USD 39.6 billion by 2027 from USD 24.5 billion in 2022, at a CAGR of 10.1% from 2022 to 2027.

Major Growth Boosting Factors:

The demand for oncology medications, antibody-drug conjugates, top pharmaceutical firms' expanding emphasis on HPAPIs, improvements in HPAPI manufacturing methods, and an increasing emphasis on precision medicine are some of the drivers propelling this market's expansion.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=36582475

Data Triangulation:

After arriving at the overall market size, the total market was split into several segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all the segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides. Along with this, the market was validated using both top-down and bottom-up approaches.

The Oncology segment is expected to account for the largest share of the market in 2021.

On the basis of therapeutic application, the market is segmented into oncology, hormonal imbalance, glaucoma, and other therapeutic applications. The oncology segment is expected to account for the largest share of the global market in 2018. The growing incidence and prevalence of cancer across the globe and the launch of new target therapies in addition to technological advancements in the oncology HPAPI-antibody conjugate technology are major factors contributing to the growth of this segment.

Geographical Growth Scenario:

The Asia region is the fastest-growing region of High Potency APIs/HPAPI Market from 2022 to 2027

North America, Europe, Asia, and the Rest of the World (RoW) comprise the segments of the HPAPI market. Throughout the projection period, Asia is anticipated to grow at the fastest rate. The Asian market is expanding due to a number of factors, including the aging population, the high prevalence of chronic and lifestyle diseases, the rise in disposable income, the prevalence of age- and lifestyle-related diseases, government initiatives to improve healthcare and promote the use of generics, and the region's expanding market for merchant manufacturers because of its low labor and manufacturing costs.

Global Key Players:

The major players in the HPAPI market include Pfizer Inc. (US), Novartis International AG. (Switzerland), Sanofi (France), Hoffmann La-Roche (Switzerland), and Bristol Myers Squibb Company (US).

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=36582475

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA : 1-888-600-6441 sales@marketsandmarkets.com

[maddyslensecraft]

The global size of tablet coatings market in terms of revenue was estimated to be worth USD 739 million in 2020 and is poised to reach USD 969 million by 2025, growing at a CAGR of 5.6% from 2020 to 2025. The research study consists of an industry trend analysis, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Growth in this market is majorly driven by the growing pharmaceutical industry coupled with the increasing R&D activities taking place in this field. The growing generics market, rapidly growing biopharmaceuticals sector, growing nutraceutical industry, and the rising adoption of orphan drugs are supporting the growth of the market.

[maddyslensecraft]

The global environmental testing equipment market is estimated to reach USD 1.6 billion by 2027 from USD 1.1 billion in 2022, at a CAGR of 7.6% during the forecast period (2022-2027). Growth in the environmental testing market is mainly driven by the rising levels of environmental pollution worldwide, increasing efforts from public/private organizations to raise awareness about environment protection, privatization of environmental testing and treatment services, and increasing funding on wastewater treatment projects/programs. Increasing industrial activities post COVID-19, and the growing utilization of mobile & portable systems are also expected to provide a wide range of growth opportunities for players in the market. On the other hand, high capital investments for accurate and sensitive analytical testing and inadequate supporting infrastructure coupled with the shortage of skilled professionals are factors expected to limit market growth to a certain extent in the coming years.

[maddyslensecraft]

Environmental Testing Equipment Market worth $1.6 billion by 2027

Major Growth Driving Factors:

The global increase in environmental pollution, the increased efforts of public and private organizations to promote environmental protection, the privatization of environmental testing and treatment services, and the expansion of funding for wastewater treatment projects and programs are the primary factors propelling the growth of the environmental testing market.

Following COVID-19, there will likely be a rise in industrial activity, and the use of mobile and portable systems will also likely increase, offering market participants a variety of options for expansion. On the other hand, factors that are anticipated to restrict market expansion in the upcoming years include high capital expenditures for sensitive and accurate analytical testing, insufficient supporting infrastructure, and a shortage of experienced specialists.

Projected Surge in Revenue Generation:

The market for environmental testing equipment is expected to grow at a compound annual growth rate (CAGR) of 7.6% from USD 1.1 billion in 2022 to USD 1.6 billion in 2027.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=149706080

Water quality testing to dominate the environmental testing equipment market, by application, during the forecast period

Based on application, the environmental testing equipment market is segmented into water quality testing, air quality testing, and soil quality testing. In 2021, the water quality testing application segment accounted for the largest share of the market. The large share of this segment can be attributed to the increasing industrial activities worldwide, which, in turn, has led to rising disposal levels of industrial wastewater and effluents into water bodies.

The government agencies and municipal authorities segment accounted for the largest market share in the global environmental testing equipment market in 2021

Based on end users, the environmental testing equipment market is segmented into government agencies and municipal authorities, environmental testing laboratories, industrial facilities, commercial and residential facilities, and other end users. The government agencies and municipal authorities segment accounted for the largest environmental testing equipment market share in 2021. The large share of this segment can be attributed to active government participation in environmental testing and pollution monitoring, especially in emerging countries with alarming pollution levels.

Conventional/benchtop platforms segment accounted for the largest market share in the global environmental testing equipment market in 2021

Based on platform, the environmental testing equipment market is segmented into conventional/benchtop platforms, portable/mobile platforms, and handheld platforms. The conventional/benchtop platforms segment accounted for the largest environmental testing equipment market share in 2021. The large share of this segment can be attributed to the increasing adoption of these platforms among environmental testing laboratories & government agencies owing to their accuracy

Geographical Growth Dynamics:

North America to dominate the environmental testing equipment market during the forecast period

North America accounted for the largest share of the global environmental testing equipment market in 2021. The large share of the market in North America is attributed to factors such as the growing funding for environmental testing in the US, widespread usage of environmental testing equipment in the pharmaceutical sector, growing food safety concerns in the US, and government initiatives to improve lab infrastructure and propel fundamental scientific research in Canada.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=149706080

Key Players:

The top players who dominated the environmental testing equipment market include Agilent Technologies Inc. (US), Thermo Fisher Scientific Inc. (US), Shimadzu Corporation (Japan), Waters Corporation (US), Bruker Corporation (US), PerkinElmer Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), JEOL Ltd. (Japan), Endress+Hauser Group Services AG (Analytik Jena, Switzerland), JASCO Corporation (Japan), Teledyne Technologies Incorporated (US), AMETEK, Inc. (US), and INFICON (Switzerland), among others. The major players are focused on expanding their presence in emerging markets such as Latin America, the Middle East, and the Asia Pacific. In the Asia Pacific region, the market in China is expected to grow at the highest CAGR due to the growing focus on environmental pollution monitoring & control, especially air pollution, in the country.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA : 1-888-600-6441 sales@marketsandmarkets.com

[maddyslensecraft]

The global antimicrobial susceptibility testing market in terms of revenue was estimated to be worth $3.6 billion in 2022 and is poised to reach $4.7 billion by 2027, growing at a CAGR of 5.5% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The rising prevalence of infectious diseases, high antibiotic resistance, and supportive government attempts to lessen the burden of infectious diseases are all factors contributing to the growth of the antimicrobial susceptibility testing (AST) market. The use of antibiotic susceptibility testing is growing due to an increase in certain illnesses, such as bloodstream infections and pneumonia brought on by E. coli, K. pneumonia, and P. aeruginosa, among others.

[maddyslensecraft]

Antimicrobial Susceptibility Testing Market - Future Revenue Growth Forecasts by 2027

Overview of This Study:

This research employed a large number of primary and secondary sources. In order to determine the segmentation kinds, industry trends, major players, competitive landscape, important market dynamics, and major player strategies, the research procedure entailed analyzing a variety of industry-affecting aspects.

Market Size Estimation:

The revenue share analysis of the top competitors in the antimicrobial susceptibility testing market was used to determine the market size in this study. In order to achieve this, major market participants were identified, and their earnings from the medical aesthetics industry were calculated using a variety of insights obtained throughout the main and secondary research stages. Examining the annual and financial reports of the leading market participants was one aspect of secondary research. On the other hand, in-depth interviews with significant thought leaders, including directors, CEOs, and important marketing executives, were a part of the primary study.

To calculate the global market value, segmental revenues were calculated based on the revenue mapping of major solution/service providers. This process involved the following steps:

# Generating a list of major global players operating in the microcatheter market. # Mapping annual revenues generated by major global players from the product segment (or nearest reported business unit/product category). # Revenue mapping of major players to cover major share of the global market share, as of 2021. # Extrapolating the global value of the automated antimicrobial susceptibility testing market.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=206359984

Major Growth Driving Factors:

The rising prevalence of infectious diseases, high antibiotic resistance, and supportive government measures to lessen the burden of infectious diseases can all be linked to the expansion of the antimicrobial susceptibility testing (AST) industry. The use of antimicrobial susceptibility testing is growing due to an increase in specific illnesses such pneumonia and bloodstream infections caused by E. coli, K. pneumoniae, P. aeruginosa, and others.

Revenue Growth Projections:

According to revenue estimates, the global market for antimicrobial susceptibility testing was valued at $3.6 billion in 2022 and is expected to increase at a compound annual growth rate (CAGR) of 5.5% to reach $4.7 billion by 2027.

Data Triangulation:

After arriving at the overall market size from the market size estimation process explained above, the Antimicrobial susceptibiity testing marketwas split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the antimicrobial susceptibility testing market was validated using both top-down and bottom-up approaches.

Driver: Substance abuse-related emergence of multidrug resistance

Antibiotics are getting less and less effective as drug resistance rises globally, making diseases more difficult to treat and ultimately leading to mortality. For example, new medicines are desperately needed to treat gram-negative bacterial infections that are resistant to carbapenem, as per the WHO priority pathogen list. Regretfully, if people do not change the way antibiotics are now utilized, these unique medications will suffer the same fate as the current antibiotics and become worthless.

Restraint: High Cost of automated Laboratory Instruments

Automated antimicrobial laboratory equipment has top-of-the-line features and functions, and it costs a lot of money. The incubation and detection times are shortened by the use of automated AST systems. The high cost of maintenance for these devices, which are well-equipped with cutting-edge software that requires routine upkeep, is another hurdle to this industry.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=206359984

Opportunity: Prospects for expansion in developing economies

Players in the antimicrobial susceptibiity testing market have a lot of chances in emerging nations like APAC, China, India, and Japan. The market for antimicrobial susceptibility testing is expanding in these nations due to the quick rise in medical tourism, the population expansion of adults (those over 20), and the rise in drug usage. These nations are also home to a workforce that is highly skilled and knowledgeable about cutting-edge technologies.These nations are also underdeveloped in most areas and have lax import/export regulations, which may aid businesses in building their brands. The regions are benefiting from a growing number of technicians who are eager to learn about new technologies and who are upgrading their skills.

Key Players:

As of 2021, prominent players in the market are include bioMérieux SA (France), Becton, Dickinson, and Company (US), Thermo Fisher Scientific (US), Danaher Corporation (US), Bio-Rad Laboratories, Inc. (US) among others.

Different Growth Strategies Adopted by Them:

Most companies in the market focus on organic and inorganic growth strategies, such as service launches, expansions, acquisitions, partnerships, agreements, and collaborations, to increase their service offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA : 1-888-600-6441 sales@marketsandmarkets.com

[maddyslensecraft]

The global peptide synthesis market in terms of revenue was estimated to be worth $601 million in 2023 and is poised to reach $859 million by 2028, growing at a CAGR of 7.4% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Various elements such as increasing R&D activities, increasing government funding for drug discovery research, and growing pharmaceutical & biological industries are the major growth factors for this market. Many peptide-based research projects are also being fostered by increasing collaborative partnerships among various companies this factor is further driving market growth.

[maddyslensecraft]

Peptide Synthesis Market: Major Growth Driving Factors & Revenue Growth Projections

Overview of This Study:

In order to estimate the current size of the peptide synthesis market, this study covered four primary operations. A thorough investigation was conducted using secondary research methods to gather data about the market, its parent market, and its peer markets. The following stage involved conducting primary research to confirm these conclusions, hypotheses, and sizing with industry experts throughout the value chain. To estimate the total market size, various methodologies, including top-down techniques, were utilized. The market size of the various segments and subsegments was then estimated using data triangulation techniques and market breakdown.

Market Size Estimation:

To determine and validate the overall size of the peptide synthesis market, a top-down methodology was employed. Additionally, this approach was widely utilized to calculate the market's subsegment sizes. The following is a list of the research methods utilized to determine the market size:

# The key players in the industry and market have been identified through extensive secondary research. # The revenues generated from the peptide synthesis business of leading players have been determined through primary interviews and secondary research. # All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=158927365

Major Growth Driving Factors:

The expanding medicinal uses, technological developments in peptide synthesis, and rising peptide demand are driving growth in this market. In addition, increased spending on R&D, a thriving industry, and the use of peptides in pharmaceutical products are some of the key factors expected to propel market expansion. Nonetheless, during the course of the forecast period, the absence of a single set of laws pertaining to therapeutic peptides and the high cost of instruments are anticipated to impede the market's expansion.

Revenue Growth Projections:

The global peptide synthesis market in terms of revenue was estimated to be worth $601 million in 2023 and is poised to reach $859 million by 2028, growing at a CAGR of 7.4% from 2023 to 2028.

Data Triangulation:

Following the completion of the market size assessment process, the entire market was divided into a number of segments and sub-segments. Data triangulation and market breakdown processes were used where appropriate to finish the entire market engineering process and yield precise statistics for all segments and subsegments. Through an analysis of numerous variables and patterns from the supply and demand sides, the data was triangulated.

Driver: Peptides are being used in pharmaceutical products more often.

Peptides are very specific and very potent pharmaceutical ingredients. They have a wide range of therapeutic applications because of the diversity of their biological roles. Because of their wide molecular space, high biological activity, high specificity, simplicity of synthesis, accessibility, and low toxicity, peptides are making their way into the drug development process as possible active medicinal ingredients. Because of their therapeutic potential, high specificity and low toxicity, versatility and diversity, improvements in peptide synthesis technologies, potential use as drug candidates, emergence of personalized medicine, and rising interest in and funding for peptide-based therapeutics, peptides are becoming more and more common in the pharmaceutical industry. All of these elements work together to make peptides a more important class of molecules in the creation of innovative and focused pharmacological treatments.

Restraint: Exorbitant instrument costs

High-throughput, quick systems are used in the synthesis of proteins. Advanced features and functions in chromatography equipment, such as peptide synthesizers, typically come at a premium price. Users of peptide synthesizers have total control over the synthesis process and can choose from fully automated, manual, or semi-automated models. Peptide synthesizers range in price from USD 300,000 to USD 250,000, depending on the automation and cutting-edge technologies they support. It is challenging for developing nations to experiment with peptide synthesis due to the exorbitant costs of the necessary tools. These instruments are expensive because of advances in technology. Furthermore, it is expensive to maintain these devices because it calls for consumables, chemicals, spare parts, and regular servicing.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=158927365

Opportunity: Creation of individualized medications

The peptide synthesis sector has significant growth prospects due to the emergence of personalized medicine. Peptides provide the necessary targeting, customisation, and specificity to enable individualized treatment plans. It is anticipated that the need for peptide synthesis technology, services, and products will increase dramatically as personalized medicine continues to develop and gain popularity.

Key Players:

The prominent players operating in the peptide synthesis market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Kaneka Corporation (Japan), GenScript Biotech Corporation (China), and Bachem Holding AG (Switzerland).

Different Growth Strategies Adopted by Them:

Most companies in the market focus on organic and inorganic growth strategies, such as service launches, expansions, acquisitions, partnerships, agreements, and collaborations, to increase their service offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA : 1-888-600-6441 sales@marketsandmarkets.com

[maddyslensecraft]

The global NGS sample preparation market in terms of revenue was estimated to be worth $1.9 billion in 2022 and is poised to reach $4.0 billion by 2028, growing at a CAGR of 13.4% from 2022 to 2028. The key factors driving the growth of the market are use of NGS as substitute for PCR, and greater efficiency of genotyping and preparation protocols. However, ethical and privacy issues in health data are expected to restrain market growth to a certain extent.

[maddyslensecraft]

NGS Sample Preparation Market worth $4.0 billion by 2028

Overview of This Study:

In order to determine the current size of the NGS sample preparation market, this study engaged in four main actions. A thorough investigation was conducted using secondary research methods to gather data about the market, its parent market, and its peer markets. The following stage involved conducting primary research to confirm these conclusions, hypotheses, and sizing with industry experts throughout the value chain. A combination of top-down and bottom-up methods was used to assess the overall market size. Subsequently, methods for data triangulation and market breakdown were employed to estimate the market size of various segments.

Market Size Estimation:

The entire size of the NGS sample preparation market was estimated and validated using both top-down and bottom-up methods. The size of different market subsegments was also widely estimated using these techniques. The following is a list of the research methods utilized to determine the market size:

# The key players in the industry and market have been identified through extensive secondary research # The revenues generated from the NGS sample preparation business of leading players have been determined through primary and secondary research # All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=69735098

Major Growth Driving Factors:

The use of NGS as a PCR substitute, the development of NGS platforms, the decreasing cost of sequencing, the efficiency of genotyping and preparation methods, and others are some of the key drivers propelling the growth of this industry. The development of the market, however, may be hampered by the existence of substitute technologies that lack the specific knowledge and sequencing capacities of individual laboratories.

Revenue Growth Projections:

Revenue from the global NGS sample preparation market was projected to be $1.9 billion in 2022 and is expected to rise at a compound annual growth rate (CAGR) of 13.4% from 2022 to 2028, when it is expected to reach $4.0 billion.

Data Triangulation:

Following the completion of the market size estimation process, the entire market was divided into multiple parts. Data triangulation and market breakdown processes were used where appropriate to finish the entire market engineering process and provide precise statistics for every category. Through an analysis of numerous variables and patterns from the supply and demand sides, the data was triangulated.

Driver: Increased effectiveness of preparation and genotyping procedures

Due to its high resolution available for genotyping, human whole genome sequencing has been developing tremendously in recent years and has set a new standard for itself in the bacterial infection outbreak. Because NGS sample preparation is used for genotyping, it has proven to be the most important technology for investigating bacterial outbreaks. NGS sample preparation is primarily carried out using Illumina machines, while other major companies such as ThermoFisher and PerkinElmer can also be employed. Because it requires less hands-on time and can operate with small amounts of DNA, enzymatic fragmentation library preparation is superior to other techniques.

Restraint: Existence of substitute technologies

Additional methods for diagnosing different diseases include the use of Sanger, antigen testing, polymerase chain reaction (PCR), and serological testing. Sanger sequencing has dominated genomics research for the last 20 years and produced several noteworthy advances in the field. By looking for antibodies in the blood, serological tests are performed to identify the viruses present in the body. Numerous antibodies produced by the immune system can also be found by serological testing.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=69735098

Opportunity: Growing alliances and cooperation amongst important actors

Many major actors, including hospitals, clinics, academic institutions, research labs, and other pharmaceutical and biotechnology corporations, are working together. Examples of these partners include Illumina, Thermo Fisher Scientific, and PerkinElmer. New products, research projects, and technologies are being introduced to the market as a result of these tactics. The growing use of NGS sample preparation is anticipated to make these projects lucrative growth possibilities for market participants.

Key Players:

The market for NGS sample preparation is highly consolidated, with key players strategizing to capture the market. Prominent players in the NGS sample preparation market are Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), PerkinElmer Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (US), Danaher (US), Becton, Dickinson and Company (US), Merck KGAA (Germany), QIAGEN (Germany),  Bio-Rad Laboratories, Inc. (US), Promega Corporation (US), Eurofins Scientific (Luxembourg), BGI (China), 10x Genomics (US), Sysmex Corporation (US), Psomagen (US), Zymo Research Corporation (US), Takara Bio Inc. (Japan), Novogene Co., Ltd. (China), New England Biolabs (US), Tecan Trading AG (US), Oxford Nanopore Technologies PLC (UK), PacBio (US), Medgenome (US), and Swift Biosciences Inc. (US).

Different Growth Strategies Adopted by Them:

Most companies in the market focus on organic and inorganic growth strategies, such as service launches, expansions, acquisitions, partnerships, agreements, and collaborations, to increase their service offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA : 1-888-600-6441 sales@marketsandmarkets.com

[maddyslensecraft]

The global clinical trial supplies market in terms of revenue was estimated to be worth $3.9 billion in 2023 and is poised to reach $6.3 billion by 2028, growing at a CAGR of 9.9% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The clinical trials supplies market's growth is influenced by a combination of various factors such as increasing prevalence of diseases, rise in number of clinical trials and robust regulatory support for clinical trials. Furthermore, increasing industrial collaborations for drug development is likely to give momentum to clinical trials supplies market growth.

[maddyslensecraft]

Clinical Trial Supplies Market: Emerging Trends & Global Future Forecasts

Overview of This Study:

In order to determine the current size of the clinical trial supplies market, this study engaged in four main actions. A thorough investigation was conducted using secondary research methods to gather data about the market, its parent market, and its peer markets. The following stage involved conducting primary research to confirm these conclusions, hypotheses, and sizing with industry experts throughout the value chain. A combination of top-down and bottom-up methods was used to assess the overall market size. The market size of the various segments and subsegments was then estimated using data triangulation techniques and market breakdown.

Market Size Estimation:

Several methods were used to assess the clinical trial supplies market's size globally. The value of the market and other associated submarkets was estimated and validated using a thorough market estimating methodology. The size of different market subsegments was also widely estimated using these techniques. The following is a list of the research methods utilized to determine the market size:

# The major players in the industry and market have been identified through extensive primary and secondary research. # The revenues generated from the clinical trial supply service business of players operating in the market have been determined through secondary research and primary analysis. # All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=172240059

Major Growth Driving Factors:

A number of variables, including the rise in clinical trial numbers, the incidence of diseases, and the strong regulatory support for clinical trials, all contribute to the growth of the clinical trials supplies market. Moreover, a rise in industry partnerships for medication discovery is probably going to fuel the market expansion for clinical trial supplies.

Revenue Growth Projections:

Revenue-wise, the global clinical trial supplies market was projected to be valued $3.9 billion in 2023 and is expected to rise at a compound annual growth rate (CAGR) of 9.9% from 2023 to 2028, when it reaches $6.3 billion.

Data Triangulation:

Following the evaluation of the market's overall size by a market size estimation procedure, the market was divided into multiple segments and subsegments. Data triangulation and market breakdown processes were used where appropriate to finish the entire market engineering process and yield precise statistics for all segments and subsegments. Through an analysis of numerous variables and patterns from the supply and demand sides, the data was triangulated.

Driver: Increasing the quantity of clinical trials that are registered

The World Health Organization reports that there would be over 7,44,100 clinical studies registered worldwide in 2022, a rise in the number of registered clinical trials. The United States of America registered the most trials overall between 1999 and 2022 (168,520), ahead of China (94,193) and Japan (63,499). Of the clinical trials that had a designated phase of development, the majority (95,790) were in phase II.

The pharmaceutical industry spends the highest proportion of its sales on research and development (R&D) of all industry sectors. Statistics showing a consistent increase in the number of registered and ongoing clinical trial cases during the previous 23 years. This is the primary cause of the increase in clinical trial services that are being outsourced, including production, packing, labeling, blinding, and storage and delivery.

Restraint: High cost of drug development

There are several restrictions on clinical trial supply, including the high expense of drug development and discovery.

However, the process of researching and developing drugs for some uncommon diseases can be extremely difficult, requiring expert laborers to conduct clinical trials and a method that is prone to failure.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=172240059

Opportunity: Growth opportunities in emerging markets

North America and Europe are the two main centers for clinical trial services in the clinical trial supplies market. Furthermore, the high expense of clinical trials for their creative drug creation is a problem for these nations. Developing countries are conducting clinical trials for rare diseases that have come from this. The US-based corporation Thermo Fisher Scientific Inc. The PPD DCT Network was established to support international researchers and research centers participating in DCTs for pharmaceutical and biotech clients, according to a major player in this sector. In order to bolster the expansion of healthcare logistics, Catelent Inc. (US) purchased Bomi Group. This acquisition increased the company's global reach and strengthened its cold chain capabilities in key countries throughout Europe and Latin America.

Key Players:

The clinical trial supplies market is consolidated, with a small number of players competing for market shares.  Thermo Fisher Scientific Inc. (US), Catalent, Inc. (US), Eurofins Scientific (France), Piramal Pharma Solutions (India), PRA Health Sciences (US), Marken (A Subsidiary of UPS) (US), Parexel International (MA) Corporation (US), Biocair (UK), AlmacGroup (UK), Sharp Services, LLC (US), PCI Pharma Services (US), Nuvisan (Germany), Lonza Group (Switzerland), are some of the leading players in this market.

Different Growth Strategies Adopted by Them:

Most companies in the market focus on organic and inorganic growth strategies, such as service launches, expansions, acquisitions, partnerships, agreements, and collaborations, to increase their service offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA : 1-888-600-6441 sales@marketsandmarkets.com

[maddyslensecraft]

The global contrast media market in terms of revenue was estimated to be worth $6.3 Billion in 2023 and is poised to reach $9.7 Billion by 2029, growing at a CAGR of 7.5% from 2023 to 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.

[maddyslensecraft]

The global molecular biology enzymes market in terms of revenue was estimated to be worth $15.3 billion in 2021 and is poised to reach $29.7 billion by 2026, growing at a CAGR of 14.2% from 2021 to 2026. Growth in the global market is driven by factors such as increased research activities and R&D investments in the life science industry, rising number of genome projects, technological advancements in the life science industry, and rising incidence of genetic disorders. However, limited reimbursements for genetic testing are expected to restrain the growth of this market during the forecast period.

[maddyslensecraft]

Molecular Biology Enzymes Market: Major Revenue Surge in Predicted by 2026

Overview of This Study:

In order to estimate the current size of the molecular biology enzymes and kits & reagents market, this study covered four main tasks. A thorough investigation was conducted using secondary research methods to gather data about the market, its parent market, and its peer markets. The following stage involved conducting primary research to confirm these conclusions, hypotheses, and sizing with industry experts throughout the value chain. A combination of top-down and bottom-up methods was used to assess the overall market size. The market size of the various segments and subsegments was then estimated using data triangulation techniques and market breakdown.

Major Growth Driving Factors:

Increased R&D spending and research efforts in the life science sector, an increase in genome projects, technical developments in the life science sector, and an increase in the prevalence of genetic disorders are some of the reasons propelling the global market's growth. However, over the projected time, it is anticipated that the market's expansion will be constrained by the small reimbursements for genetic testing.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=164131709

Global Industry Segmentation:

The molecular biology enzymes and kits & reagents market was led by the kits & reagents segment in terms of product segment share in 2020.

The molecular biology enzymes and kits & reagents market is divided into two segments based on products: enzymes and kits & reagents. In 2020, the kits and reagents segment held the greatest proportion of the global market for molecular biology enzymes and kits and reagents, with 85.9%. The main reason for this segment's huge share is because consumers frequently buy these single-use products. This area is anticipated to develop at the fastest rate due to the extensive use of it by biotechnology and pharmaceutical firms.

In 2020, the molecular biology enzymes and kits & reagents market's application segment, which included polymerase chain reaction (PCR), held the greatest share.

The polymerase chain reaction (PCR), sequencing, cloning, epigenetics, restriction digestion, synthetic biology, and other applications (mutagenesis, in vitro transcription, and molecular labeling & detection) are the segments of the global molecular biology enzymes and kits & reagents market based on applications. The majority of end users use PCR equipment extensively, and PCR is increasingly being used for molecular diagnostic assays in hospitals and clinics. These factors combined to give the polymerase chain reaction (PCR) segment the largest share of the molecular biology enzymes and kits & reagents market in 2020—28.3%.

Geographical Growth Scenario:

The Asia Pacific region is the fastest-growing region of the molecular biology enzymes and kits & reagents market in 2020.

The market in the APAC is expected to grow at the highest rate during the forecast period. Growth in the APAC market is driven by increasing government interest in the biomedical & biotechnology industries, the presence of bio-clusters in India and China, and the growing outsourcing of clinical research activities to Asian countries.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=164131709

Global Key Players:

The global molecular biology enzymes and kits & reagents market is highly consolidated. Key players in the molecular biology enzymes and kits & reagents market include Thermo Fisher (US), Merck (Germany), Illumina (US), QIAGEN (Netherlands), New England Biolabs (US), Promega (US), Agilent (US), Roche (Switzerland), Takara Bio (Japan), Bio Basic (Canada), Jena Bioscience (Germany), Molecular Biology Resources (US), Bio-Rad Laboratories, Inc. (US).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA : 1-888-600-6441 sales@marketsandmarkets.com

[maddyslensecraft]

The global cell isolation market in terms of revenue was estimated to be worth $4.4 billion in 2023 and is poised to reach $8.2 billion by 2028, growing at a CAGR of 13.4% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.